Hoffman v. Hampshire Labs, Inc.

963 A.2d 849, 405 N.J. Super. 105
CourtNew Jersey Superior Court Appellate Division
DecidedJanuary 30, 2009
DocketA-3401-07T1
StatusPublished
Cited by56 cases

This text of 963 A.2d 849 (Hoffman v. Hampshire Labs, Inc.) is published on Counsel Stack Legal Research, covering New Jersey Superior Court Appellate Division primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hoffman v. Hampshire Labs, Inc., 963 A.2d 849, 405 N.J. Super. 105 (N.J. Ct. App. 2009).

Opinion

963 A.2d 849 (2009)
405 N.J. Super. 105

Harold M. HOFFMAN, Plaintiff-Appellant,
v.
HAMPSHIRE LABS, INC. and Video Age, Inc., Defendants-Respondents.

No. A-3401-07T1

Superior Court of New Jersey, Appellate Division.

Argued November 18, 2008.
Decided January 30, 2009.

*850 Harold M. Hoffman, appellant, argued the cause pro se.

Scott Shaffer, New York City, argued the cause for respondents (The Lustigman Firm, P.C., attorneys; Mr. Shaffer, of counsel; Andrew B. Lustigman and Jill L. Abitbol, on the brief).

Before Judges PARKER, YANNOTTI and LeWINN.

The opinion of the court was delivered by

YANNOTTI, J.A.D.

Plaintiff Harold M. Hoffman appeals from an order entered by the trial court on March 14, 2008, which dismissed his complaint with prejudice pursuant to Rule 4:6-2(e). For the reasons that follow, we modify the trial court's order to provide for dismissal of the complaint without prejudice and affirm.

On November 26, 2007, plaintiff filed a complaint in the trial court individually and on behalf of a class of persons who purchased a product called Herculex. Plaintiff claimed that defendants Hampshire Labs, Inc. and Video Age, Inc. "advertised, promised and represented" to consumers through "print, internet and other media" that the product contained certain ingredients "`that are quickly transported through the tissues of the penis causing a surprisingly large erection to occur in no time at all[.]'"

According to the complaint, defendants' advertisements included various statements about the product, including claims that the product would "`[i]nduce the biggest erections of your life;'" "`[i]nduce a harder, stiffer, more rigid erection;'" "`[i]nduce one erection after another;'" and "`[c]ause female partners to experience spine-quaking orgasms[.]'" These, and other results, were "`guaranteed.'"

Plaintiff further alleged that, "[u]pon information and belief," he and other members of the class heard defendants' advertisements, promises and representations and purchased the product from defendants. Plaintiff claimed that, "[u]pon information and belief," the aforementioned "advertisements, promises and representations" are "false, deceptive, fabricated; constitute a misrepresentation; constitute an unconscionable trade practice; are replete with material omissions; constitute a sharp and deceitful marketplace practice, and are a false promise." Plaintiff asserted that, "[u]pon information and belief," the product "does not, and lacks [the] capacity, to" produce the results "promised, advertised and represented by defendants."

Based on these allegations, plaintiff asserted five claims under the Consumer Fraud Act (CFA), N.J.S.A. 56:8-1 to -60. Plaintiff alleged that defendants' conduct constitutes "an unconscionable commercial practice," "deception," "fraud," "false pretense, false promise and/or misrepresentation," and "knowing concealment, suppression *851 and/or omission of material facts" in violation of the CFA. Plaintiff claimed that he and members of the putative class sustained monetary losses as a result of defendants' violations of the CFA. Plaintiff sought treble damages, punitive damages, pre-judgment and post-judgment interest, fees, costs, attorney's fees and penalties.

Plaintiff also asserted a claim for common law fraud. Plaintiff alleged that, in their marketing and sale of Herculex, defendants had

deliberately engaged in deception, false pretense, false promise and/or misrepresentation with respect to material facts, and did so with the intent that others, including members of the plaintiff-class, rely upon same, and, upon information and belief, members of the class did justifiably rely upon same to their detriment.

Plaintiff further asserted that defendants had "deliberately and knowingly" concealed "material facts with the intent that others, including members of the plaintiff-class," would rely thereon. Plaintiff said that, "upon information and belief," members of the class had relied "upon same to their detriment." Plaintiff further alleged that he and members of the putative class had been damaged as a proximate result of defendants' conduct.

On January 16, 2008, defendants filed a motion pursuant to Rule 4:6-2(e) to dismiss the complaint for failure to state a claim upon which relief could be granted. In a certification filed in support of that motion, William Hudlow, defendants' president, stated that plaintiff had placed "his first and only order for Herculex on November 21, 2007." Hudlow also stated that the product had been shipped to plaintiff.

Defendants argued that plaintiff failed to state a claim under the CFA because he had not alleged specific facts to show that defendants violated the CFA or that plaintiff or any member of the putative class had sustained an "ascertainable loss" as required by N.J.S.A. 56:8-10. Defendants further argued that the facts as alleged by plaintiff were insufficient to state a claim of fraud under the common law.

Plaintiff opposed the motion. In his certification, plaintiff stated that he had placed his order for Herculex on November 20, 2007 and suffered a monetary loss on November 21, 2007, when his credit card was charged for the purchase price of the product and shipping costs. Plaintiff asserted that the product had been shipped to him on November 21, 2007. Plaintiff said that, "[i]n all likelihood," he had the product "in his possession" when he filed his complaint on November 26, 2007.

Plaintiff stated, however, that "it hardly matters" whether he received the product before he filed his lawsuit because he had decided to sue defendants after he "examined" defendants' internet website and identified the ingredients of the product. According to plaintiff, the product contains polysorbate, sodium lactate glycerin, saw palmetto, capsicum, aspartame, and caffeine.

Plaintiff said that polysorbate is "an oily liquid used in cosmetics;" sodium lactate glycerin is "used to harden soap[;]" saw palmetto is "an unregulated product" that had not been evaluated by the United States Food and Drug Administration and is "sold by pseudo-scientists and other charlatans[;]" capsicum "may take the form of cayenne pepper" or similar spices; and aspartame is "an artificial sweetener[.]" Plaintiff stated that he suffered a monetary loss when he "reached the reasoned conclusion that water, oil, soap hardener, hot pepper and sweetened coffee *852 were not going to induce anything approximating the promises and representations made by defendant[s] concerning the product."

Appended to plaintiff's certification was a copy of an advertisement for the product that had been mailed to plaintiff's home. The advertisement set forth various claims for the product. The advertisement stated that the product would provide "instant control" and the user would not "have to wait hours to feel the effects like expensive prescription pills." The advertisement stated that the product contained no drugs but suggested that before using the product, the purchaser should consult a "healthcare advisor." The advertisement also stated that, if the purchaser was not satisfied with the product, the purchaser would not have to "pay a single penny."

The trial court heard defendants' motion on March 14, 2008, and placed its decision on the record that day. The court first addressed plaintiff's CFA claims. The court found that plaintiff's CFA claims were deficient for several reasons:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mary E. Oxley Dean v. John G. Dean, IV
New Jersey Superior Court App Division, 2026
Robert Ottmann v. Christopher Hanlon
New Jersey Superior Court App Division, 2026
Shaun Morrell v. Retrofitness, LLC
New Jersey Superior Court App Division, 2026
Dewan N. Arefin v. the Doherty Group, Inc.
New Jersey Superior Court App Division, 2025
John William Myers v. Gny Mutual Insurance Company
New Jersey Superior Court App Division, 2025
991, LLC v. Ssomm, LLC
New Jersey Superior Court App Division, 2025
Randy Hopkins, Etc. v. Convergent Outsourcing, Inc.
New Jersey Superior Court App Division, 2025
Latonya Miller, Etc. v. Americollect, Inc.
New Jersey Superior Court App Division, 2025
Angel Cruz v. Aspen Landscaping Contracting Inc.
New Jersey Superior Court App Division, 2024
Peter Paluch v. Cuna Mutual Group
New Jersey Superior Court App Division, 2024
Jamie Baux-Johnson v. Norkia Home Improvements, LLC
New Jersey Superior Court App Division, 2024
Stonefield Investment Fund III, LLC v. L and J Enterprises 1, LLC
New Jersey Superior Court App Division, 2024
Roxana Gaviria v. Board of Education of the City of Elizabeth
New Jersey Superior Court App Division, 2024

Cite This Page — Counsel Stack

Bluebook (online)
963 A.2d 849, 405 N.J. Super. 105, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hoffman-v-hampshire-labs-inc-njsuperctappdiv-2009.